Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | 0.004 | 0.0598 | 1 | |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0251 | 1 | 0.5 |
Mycobacterium tuberculosis | Probable phosphoribosylformylglycinamidine CYCLO-ligase PurM (AIRS) (phosphoribosyl-aminoimidazole synthetase) (air synthase) | 0.004 | 0.0598 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.7003 | 0.5 |
Mycobacterium ulcerans | phosphoribosylamine--glycine ligase | 0.018 | 0.6834 | 1 |
Echinococcus multilocularis | geminin | 0.0184 | 0.7003 | 0.5 |
Echinococcus granulosus | geminin | 0.0184 | 0.7003 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0184 | 0.7003 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | phosphoribosylamine--glycine ligase | 0.018 | 0.6834 | 1 |
Mycobacterium leprae | PROBABLE PHOSPHORIBOSYLAMINE--GLYCINE LIGASE PURD (GARS) (GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE) (PHOSPHORIBOSYLGLYCINAMIDE SYNT | 0.018 | 0.6834 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.033 uM | Compound was evaluated in vitro for inhibition of growth of MCF-7 human breast adenocarcinoma using 72 hours continuous exposure | ChEMBL. | 1573633 |
IC50 (functional) | = 0.033 uM | Compound was evaluated in vitro for inhibition of growth of MCF-7 human breast adenocarcinoma using 72 hours continuous exposure | ChEMBL. | 1573633 |
IC50 (functional) | = 0.7 uM | Compound was evaluated for inhibition of [3H]-methotrexate uptake into MOLT-4 cells | ChEMBL. | 1573633 |
IC50 (functional) | = 0.7 uM | Compound was evaluated for inhibition of [3H]-methotrexate uptake into MOLT-4 cells | ChEMBL. | 1573633 |
IC50 (binding) | = 3.1 uM | In vitro inhibition of hog liver GAR transformylase with (6R)-10-formyl-FH4 as cofactor | ChEMBL. | 1573633 |
IC50 (binding) | = 3.1 uM | In vitro inhibition of hog liver GAR transformylase with (6R)-10-formyl-FH4 as cofactor | ChEMBL. | 1573633 |
IC50 (functional) | = 79.3 uM | In vitro inhibitory activity of the compound against MOLT-4 T-cell leukemia cell AICAR transformylase | ChEMBL. | 1573633 |
IC50 (functional) | = 79.3 uM | In vitro inhibitory activity of the compound against MOLT-4 T-cell leukemia cell AICAR transformylase | ChEMBL. | 1573633 |
Km (binding) | = 4.3 uM | Km value of Hog Folyl-polyglutamate synthase in presence of the compound relative to aminopterin | ChEMBL. | 1573633 |
Km (binding) | = 4.3 uM | Km value of Hog Folyl-polyglutamate synthase in presence of the compound relative to aminopterin | ChEMBL. | 1573633 |
Vmax (binding) | = 107.3 % | Percent Vmax of Hog Folyl-polyglutamate synthase in presence of the compound relative to aminopterin | ChEMBL. | 1573633 |
Vmax (binding) | = 107.3 % | Percent Vmax of Hog Folyl-polyglutamate synthase in presence of the compound relative to aminopterin | ChEMBL. | 1573633 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 1573633 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.